Baird Downgrades PAREXEL International (PRXL) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
PAREXEL (PRXL) PT, Estimates Lowered at Evercore ISI
October 27, 2016 12:24 PM EDTEvercore ISI analyst Ross Muken lowered his price target on PAREXEL International (NASDAQ: PRXL) to $70.00 (from $79.00) but maintained a Buy rating following results.
The firm cut FY 2017 EPS from $4.05 to $3.75, FY 2018 EPS from $4.80 to $4.55 and FY 2019 EPS from $5.70 to $5.50.
Muken commented: ": This was not a pleasant quarter for anyone involved (unless you are short the stock) as most metrics missed and commentary on the remainder of 2017 did not inspire confidence.... More
Jefferies Cuts Price Target on Parexel (PRXL) to $67 Following Weak 1Q
October 27, 2016 9:33 AM EDTJefferies maintained a Hold rating on PAREXEL International (NASDAQ: PRXL), and cut the price target to $67.00 (from $72.50), following the company's 1Q earnings report. EPS fell 10c below consensus and guidance midpoint. PRXL's revenue shortfall accounted for ~4c. Updated guidance reduces revenue by... More
Parexel (PRXL) Misses Q1 EPS by 10c; Guides Below, Announces $200M Stock Buyback Plan
October 26, 2016 4:24 PM EDTParexel (NASDAQ: PRXL) reported Q1 EPS of $0.76, $0.10 worse than the analyst estimate of $0.86. Revenue for the quarter came in at $0 versus the consensus estimate of $524.79 million.
Board approved new $200 million share repurchase program.
GUIDANCE:
Parexel sees... More



